Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control Validation
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the effect of moxifloxacin on the QT interval in
order to gain information on the validity of results that will be collected during another
clinical study testing riociguat in patients with pulmonary arterial hypertension (PATENT-1
study).
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination